This prognostic model, which was based on four critical immune-related genes, STC2, BIRC5, EPO and GLP1R, was demonstrated excellent performance in both prognosis and immune response prediction of HCC. This evidence concerns the gene BIRC5 and hepatocellular carcinoma.